100 QUESTIONS IN CARDIOLOGY

fish oil capsules, high dose 21
flecainide
atrial fibrillation cardioversion 139
ICD patients 189
paroxysmal atrial fibrillation 133
flying after myocardial infarction 6666 – – 77
foramen ovale, patent, reference for
closure 115555 – – 66
Fragmin During Instability in
Coronary Artery Disease
(FRISC) trial 38, 45
Framingham Heart Study, mortality
data 120–1

gemfibrozil 21, 22–3
gene therapy, prevention of restenosis
following PTCA 48–9
GISSI-2 study 52
glibenclamide 82
glycaemia, control following CABG
82–3
glyceryl trinitrate (GTN), sublingual 35
glycoprotein IIb/IIIa inhibitors,
unstable angina 44
GUSTO trials 52, 53
GUSTO IIa 38
GUSTO IIb angioplasty substudy 55

heart failure
ACE inhibitors and AT1-receptor
blockers 111111 – – 1133
beta blockers 116, 111188 – – 1199
chronic, role of vasodilators 111144 – – 1155
congestive, endocarditis in 204
digoxin in 111166 – – 1177
morbidity and mortality 220066 – – 77
prognosis, NYHA functional
capacity score and 112200 – – 22
Heart Outcomes Prevention
Evaluation (HOPE) study 64
heparin
elective surgery in mechanical heart
valve patients 202–3
unstable angina 44
use in pregnancy 196, 197, 198,
200–1
hydralazine, malignant hypertension 15
hypercholesterolaemia
familial, drug treatment 20, 21
lipid-lowering therapy 20, 21
asymptomatic patients 1177
hypertension
after aortic coarctation repair 99–100
cardiovascular risks 11 – – 22 , 8
blood pressure lowering and 7
essential, management plan 1144
malignant, management 1155 – – 1166

pulmonary, pregnancy and 198, 199

secondary causes, screening for 55 – – 66

treatment

decisions 77 – – 99

see alsoantihypertensive therapy

24-hour monitoring 33 – – 44

white coat 4

Hypertension Optimal Treatment

(HOT) study 8

hypertensive encephalopathy 15

hyperthyroidism, amiodarone-

induced 179–80

hypertrophic cardiomyopathy (HCM)

investigation/diagnosis 110011 – – 22

children 107

relatives of patients 110066 – – 77

sudden death and 177, 178

risk factors 101–2, 104

treatment 110033 – – 44

pacing 110055

hypothyroidism, amiodarone-induced

180

immunosuppressive therapy,

transplant patients 112299 – – 3300

implantable cardioverter defibrillator

(ICD)

follow-up of patients 119900 – – 11

hypertrophic cardiomyopathy 104

indications for 118855 – – 77

VT stimulation studies 182, 183

interaction with drugs 189

long QT syndrome 175

multiple shocks from 119922 – – 33

non-sustained ventricular

tachycardia 171–2

patient management 118888 – – 99

survival benefits 118844 – – 55

implantable loop recorder (ILR) 162

insulin, following CABG 82–3

internal mammary artery grafts 76–7

ISIS-3 study 52

isosorbide dinitrate (ISDN) 35

isosorbide mononitrate (ISMN) 35

labetalol, hypertensive

encephalopathy 15–16

lanoteplase 53

Late Assessment of Thrombolytic

Efficiency (LATE) study 51

Left Ventricular Assist Device (LVAD)

112233 – – 44

left ventricular function, impaired,

ACE-inhibitor treatment 111

lipid-lowering therapy

asymptomatic

hypercholesterolaemia 1177

Index 219